Alto Neuroscience (ANRO)
23.32
0.00 (0.00%)
Upcoming Events
Latest Headlines
Alto Neuroscience (ANRO) PT Raised to $60 at H.C. Wainwright
October 20, 2026 6:54 AM - StreetInsider
Form 4 Alto Neuroscience, Inc. For: Oct 02 Filed by: Smith Nicholas Conrad
October 5, 2026 4:59 PM - SEC Filing
Form 4 Alto Neuroscience, Inc. For: Sep 29 Filed by: Smith Nicholas Conrad
October 1, 2026 9:34 PM - SEC Filing
Form 144 Alto Neuroscience, Inc. Filed by: Smith Nicholas Conrad
September 29, 2026 4:24 PM - SEC Filing
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
September 9, 2026 8:03 AM - BizWire
Form 8-K Alto Neuroscience, Inc. For: Aug 26
August 27, 2026 5:19 PM - SEC Filing
Alto Neuroscience promotes Nick Smith to president and CFO
August 27, 2026 4:05 PM - StreetInsider
Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer
August 27, 2026 4:05 PM - BizWire
Alto Neuroscience (ANRO) PT Raised to $55 at H.C. Wainwright
August 18, 2026 6:39 AM - StreetInsider
Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: PERCEPTIVE ADVISORS LLC
August 14, 2026 5:19 PM - SEC Filing
Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: Vestal Point Capital, LP
August 14, 2026 4:12 PM - SEC Filing
Form SCHEDULE 13G/A Alto Neuroscience, Inc. Filed by: Sirenia Capital Management LP
August 14, 2026 8:30 AM - SEC Filing
Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
August 12, 2026 5:16 PM - StreetInsider
Form 10-Q Alto Neuroscience, Inc. For: Jun 30
August 12, 2026 4:28 PM - SEC Filing
Form 8-K Alto Neuroscience, Inc. For: Aug 12
August 12, 2026 4:15 PM - SEC Filing
Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 12, 2026 4:03 PM - BizWire
Form SCHEDULE 13G Alto Neuroscience, Inc. Filed by: BlackRock, Inc.
July 27, 2026 4:27 PM - SEC Filing
Full Article List
